6 Results for "

RFC-1

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "RFC-1" in MCE Product Catalog:

10
10 Cited Publications
Cat. No.: HY-10446
CAS No.: 146464-95-1
Purity:  99.22%
Target:  

Antifolate Apoptosis

Research Areas:  

Cancer

Pralatrexate is an antifolate and is a potent dihydrofolate reductasean (DHFR) inhibitor with a Ki of 13.4 pM. Pralatrexate is a substrate for folylpolyglutamate synthetase with improved cellular uptake and retention. Pralatrexate has antitumor activities and has the potential for relapsed/refractory T-cell lymphoma treatment [1] . Pralatrexate is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-RS11865
Research Areas:  

Others

RFC1 Human Pre-designed siRNA Set A contains three designed siRNAs for RFC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS22297
Research Areas:  

Others

Rfc1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rfc1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS28820
Research Areas:  

Others

Rfc1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Rfc1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
loading...
    loading...
Cat. No.: HY-RS13047
Research Areas:  

Others

SLC19A1 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC19A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-10446R
CAS No.: 146464-95-1
Research Areas:  

Cancer

Pralatrexate (Standard) is the analytical standard of Pralatrexate. This product is intended for research and analytical applications. Pralatrexate is an antifolate and is a potent dihydrofolate reductasean (DHFR) inhibitor with a Ki of 13.4 pM. Pralatrexate is a substrate for folylpolyglutamate synthetase with improved cellular uptake and retention. Pralatrexate has antitumor activities and has the potential for relapsed/refractory T-cell lymphoma treatment [1] . Pralatrexate is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...